Should we apply sorafenib in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy?

OBJECTIVE: Microvascular invasion (MVI) has been proved to be an independent risk factor for the recurrence of HCC. If promptly treated, the recurrence rate can be reduced and the total survival time can be prolonged. The aim of this study is to analyze the effect of sorafenib on the clinical outcom...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Huang, Yun, Zhang, Zeyu, Zhou, Yufan, Yang, Jiajin, Hu, Kuan, Wang, Zhiming
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2019
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6334782/
https://ncbi.nlm.nih.gov/pubmed/30666133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S187357
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker